While the allergen challenge increases the proportion of BDCA1+ myeloid DCs (mDCs) in BAL fluids [83] and BDCA3+ mDCs in sputum [84] of patients with asthma, the proportion of DCs in the blood reduces significantly at 3–6 h after allergen inhalation [85]. The gene discussed is THBD; the disease is asthma.